Saturday, April 27, 2013

Pharmacuetical Sales Representative Whistleblower Rewards by Pharmaceutical Sales Representative Whistleblower Lawyer Jason S. Coomer

Pharmacuetical Sales Representative Whistleblowers That Expose Mass Fraud and Illegel Kickbacks Can Obtain Large Rewards by Pharmaceutical Sales Representative Whistleblower Lawyer Jason S. Coomer

In the United States, the cost of health care continues to increase creating significant problems for many Americans and the United States Economy.  A significant cause of this increase in medical costs is healthcare fraud including illegal kickbacks, off label marketing of drugs and medications, fraudulent billing practices, and other forms of Health Care fraud.   

If you are a pharmaceutical whistleblower that is aware of fraudulent off label drug marketing practices, illegal drug kickbacks, or price fixing by a pharmaceutical marketing department or pharmaceutical company, please feel free to contact Pharmaceutical Off Label Drug Marketing Fraud Whistleblower Lawyer Jason Coomer via e-mail message.

U.S. sues Novartis over kickbacks | Reuters


Authorities said the Basel-based company for a decade lavished healthy speaking fees and "opulent" meals, including a nearly $10,000 dinner for three at the Japanese restaurant, Nobu, to induce doctors to prescribe its drugs.

They said this led to the Medicare and Medicaid programs paying millions of dollars in reimbursements based on kickback-tainted claims for medication such as hypertension drugs Lotrel and Valturna and the diabetes drug Starlix.

The charges are detailed in a whistleblower lawsuit first filed against Novartis Pharmaceuticals Corp by a former sales representative in January 2011 and which the U.S. government has now joined.
Twenty-seven U.S. states, the District of Columbia and the cities of New York and Chicago are also plaintiffs in the lawsuit, which seeks triple damages under the federal False Claims Act.

"Novartis corrupted the prescription drug dispensing process," U.S. Attorney Preet Bharara in Manhattan said in a statement. "For its investment, Novartis reaped dramatically increased profits on these drugs, and Medicare, Medicaid, and other federal healthcare programs were left holding the bag."


Health Care Fraud Whistleblowers including Medicaid Fraud Whistleblowers  and Medicare Fraud Whistleblowers Have Helped The Federal and State Governments Recover Billions of Dollars and Have Received Large Financial Rewards For Exposing Health Care Fraud

Health Care Whistleblower Reward Lawsuits are the most effective method for identifying and preventing large scale health care fraud against the government.  As such, the United States and several states have enacted health care whistleblower reward laws that harness the power of economic incentives by offering large monetary rewards to whistleblowers that properly report significant fraud.  As a health care whistleblower reward lawyer, Jason Coomer works with whistleblowers to confidentially gather information regarding several different types of health care whistleblower rewards including Medicare fraud whistleblower reward lawsuits and Medicaid fraud whistleblower reward lawsuits.

For more information on this area of law, please go to the following web pages:



If you are a pharmaceutical whistleblower that is aware of fraudulent off label drug marketing practices, illegal drug kickbacks, or price fixing by a pharmaceutical marketing department or pharmaceutical company, please feel free to contact Pharmaceutical Off Label Drug Marketing Fraud Whistleblower Lawyer Jason Coomer via e-mail message.

No comments:

Post a Comment